BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8712782)

  • 1. Clinical implications of the p53 gene.
    Sidransky D; Hollstein M
    Annu Rev Med; 1996; 47():285-301. PubMed ID: 8712782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor suppressor gene p53--function and significance in gastroenterology].
    Schoppmeyer K; Keim V; Mössner J
    Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis--programmed cell death].
    Borner M
    Ther Umsch; 1998 Jul; 55(7):459-61. PubMed ID: 9702120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 8. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 11. The p53 tumour suppressor gene.
    Steele RJ; Thompson AM; Hall PA; Lane DP
    Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 in epidermoid cancer of the esophagus.
    Tanaka M; Nonogaki S; Alberti VN; Forones NM
    Hepatogastroenterology; 1999; 46(27):1765-8. PubMed ID: 10430340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53--a key gene for cancer development. Its central significance discloses itself to researchers step by step].
    Janssen K
    Fortschr Med; 1995 Dec; 113(34):48-50. PubMed ID: 8575709
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antioncogene p53 and apoptosis response: new hypotheses on the molecular bases of tumor resistance to radiotherapy].
    Corvò R
    Radiol Med; 1996 Sep; 92(3):298-302. PubMed ID: 8975319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor suppressor gene p53. Theoretical principles and their significance for pathology].
    Poremba C; Bankfalvi A; Dockhorn-Dworniczak B
    Pathologe; 1996 May; 17(3):181-8. PubMed ID: 8710788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.